Aspirin in the treatment of acute migraine attacks

References

• Silberstein SD. Migraine. Lancet363, 381–391 (2004).
   PubMed Web of Science ®Google Scholar
• Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch. Intern. Med.159, 813–818 (1999).
   PubMed Web of Science ®Google Scholar
• Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can. J. Neurol. Sci.20, 131–137 (1993).
   PubMed Web of Science ®Google Scholar
• Adelman JU, Von Seggern RL, Mannix LK. Migraine headaches: implications for management from a nationwide patient survey. Headaches11, 105–112 (1999).
   Google Scholar
• Vane JR, Botting RM (Eds). Aspirin and Other Salicylates. Chapman & Hall Medical, London, UK (1992).
   Google Scholar
• Rainsford KD (Ed). Aspirin and Related Drugs. Taylor & Francis, London, UK (2004).
   Google Scholar
• Martindale R. The Extra Pharmacopoeia. 31st Edition. London Royal Pharmaceutical Society, UK (1996).
   Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J.24, 1601–1610 (2003).
   PubMed Web of Science ®Google Scholar
• Patrono C, Bachmann F, Baigent C et al. Expert concensus document on the use of antiplatelet agents. Eur. Heart J.25, 166–181 (2004).
   PubMed Web of Science ®Google Scholar
• Kune G. Colorectal cancer chemoprevention with aspirin. Gastrointest. Oncol.4, 5–15 (2002).
   Google Scholar
• Baron JA, Cole BF, Sandler RS et al. A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med.348, 891–899 (2003).
   PubMed Web of Science ®Google Scholar
• Sandler RS, Halabi S, Baron JA et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N. Engl. J. Med.348, 883–890 (2003).
   PubMed Web of Science ®Google Scholar
• Vane JR. Inhibition of prostaglandin synthesis as a mechansim of action of aspirin-like drugs. Nature231, 232–235 (1971).
   Web of Science ®Google Scholar
• Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nature231, 235–237 (1971).
   Web of Science ®Google Scholar
• Smith WL, Marnett LJ, DeWitt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther.49, 153–179 (1991).
   PubMedGoogle Scholar
• Smith WL. Molecular mechanism of aspirin action. Drug News Persp.4, 362–366 (1991).
   Google Scholar
• Shimokawa T, Smith WL. Prostaglandin endoperoxidase synthase – the aspirin acetylation region. J. Biol. Chem.267, 12387–12392 (1992).
   PubMed Web of Science ®Google Scholar
• Vane J. Towards a better aspirin. Nature367, 215–216 (1994).
   PubMed Web of Science ®Google Scholar
• Allen KN. Aspirin – now we can see it. Knowing how aspirin interacts with its targets make it all better. Nature Med.1, 882–883 (1995).
   PubMedGoogle Scholar
• Wallace JL. Selective COX-2 inhibitors: is the water becoming muddy? Trends Pharmacol. Sci.20, 4–6 (1999).
   PubMed Web of Science ®Google Scholar
• Fitzgerald GA. Coxibs and cardiovascular disease. N. Engl. J. Med.351, 1709–1711 (2004).
   PubMed Web of Science ®Google Scholar
• Buzzi M, Sakas D, Moskowitz M. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur. J. Pharmacol.165, 251–258 (1989).
   PubMed Web of Science ®Google Scholar
• Kaube Hoskin K, Goadsby P. Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache33, 541–544 (1993).
   PubMed Web of Science ®Google Scholar
• Rowland M, Riegelman S, Harris PA, Sholkoff SD. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J. Pharm. Sci.61, 379–385 (1972).
   PubMed Web of Science ®Google Scholar
• Pedersen AK, Fitzgerald GA. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N. Engl. J. Med.311, 1206–1211 (1984).
   PubMed Web of Science ®Google Scholar
• Shen J, Wanwimolruk S, Purves RD, McQueen EG, Roberts MS. Model representation of salicylate pharmacokinetcis using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose. J. Pharmcokinet. Biopharm.19, 575–595 (1991).
   PubMedGoogle Scholar
• Tfelt-Hansen P, Olesen J. Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine. Eur. Neurol.19, 163–165 (1980).
   PubMedGoogle Scholar
• Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeuillerie G. Double-blind comparison of an acetaminophen 400 mg–codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalalgia14, 156–161 (1994).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN. Aspirin is efficacious for the treatment of acute migraine. Headache45, 283–292 (2005).
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Dowson A, Davies PTG. Mouth-dispersible aspirin in the treatment of migraine: a placebo-controlled study. Headache42, 249–255 (2002).
   PubMed Web of Science ®Google Scholar
• The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur. Neurol.32, 177–184 (1992).
   PubMed Web of Science ®Google Scholar
• Chabriat H, Joire JE, Danchot J, Grippon P, Bousser MG. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study. Cephalalgia14, 297–300 (1994).
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet346, 923–926 (1995).
   PubMed Web of Science ®Google Scholar
• Geraud G, Compagnon A, Rossi A; COZAM Study Group. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. Eur. Neurol.47, 88–98 (2002).
   PubMed Web of Science ®Google Scholar
• Titus F, Escamilla C, da Costa Palmeira MMG, Leira R, Monteiro JMP. A double-blind comparison of lysine acetylsalicylate plus metoclopramide vs ergotamine plus caffeine in migraine. Clin. Drug Invest.21, 87–94 (2001).
   Google Scholar
• Taneri Z, Petersen-Braun M. Therapie des akuten migräneanfalls mit intravenös applizierter acetylsalicylsäre. Eine plazebokontrollierte doppelblindstudie. Der. Schmerz.9, 124–129 (1985).
   Google Scholar
• Limmroth V, May A, Diener HC. Lysine-acetylsalicylic acid in acute migraine attacks. Eur. Neurol.41, 88–93 (1999).
   PubMed Web of Science ®Google Scholar
• Diener HC. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group. Cephalalgia19, 581–588 (1999).
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia4, 107–111 (1984).
   PubMed Web of Science ®Google Scholar
• Lange R, Schwarz JA, Hohn M. Acetylsalicylic acid effervescent 1000 mg (aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia20, 663–667 (2000).
   PubMed Web of Science ®Google Scholar
• Diener HC, Bussone G, de Liano H et al; EMSASI Study Group. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia24, 947–954 (2004).
   PubMed Web of Science ®Google Scholar
• Diener HC, Eikermann A, Gessner U et al. Efficacy of 1000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur. Neurol.52, 50–56 (2004).
   PubMed Web of Science ®Google Scholar
• International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine (first edition). Cephalalgia11, 1–12 (1991).
   Web of Science ®Google Scholar
• International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine (second edition). Cephalalgia20, 765–786 (2000).
   PubMed Web of Science ®Google Scholar
• Fries JF. The epidemiology of NSAID gastropathy. The ARAMIS experience. J. Clin. Rheumatol.4, S11–S16 (1998).
   Google Scholar